Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies
MUMBAI, India, June 19, 2013 /PRNewswire/ --
Bharat Book Bureau presents Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies (http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/innovative-drug-delivery-systems-novel-product-and-formulation-technology-licensing-opportunities-for-generic-pharmaceutical-companies.html)
There are more than 1400 sustained or controlled release drugs approved all over the world. Revenues within the global generics market reached an estimated value of $265 billion in 2012, showing a growth of 9.3% throughout the year. The oral drug delivery market remains the largest slice of the overall drug delivery market, with more than 52% of market share. It is presently valued at $49 billion and is expected to reach over $90 billion by 2016, at a CAGR of 11%. Global injectable drug delivery market is expected to be worth $29b by 2015. The oral drug delivery market remains the largest slice of the overall drug delivery market, with more than 52% of market share.
Novel drug delivery systems (NDDS) offer many more advantages, which include improved therapy by increasing the efficacy and duration of drug activity, increased patient compliance through decreased dosing frequency and convenient routes of administration, and improved targeting for a specific site to reduce unwanted side effects. The challenge for both drug and drug delivery companies is to deliver both existing and emerging drug technologies in a manner that improves the current benefits enjoyed by the patients. The generic market with reference to the innovative molecule (NCE) has become very competitive as several companies have already filed ANDA's for potential generic drugs in the near term. The study of the novel drug delivery companies and their formulation technologies will provide the potential value added opportunity in the generic field in terms of the patient's compliance or bioavailability enhancement.
Highlights of the report:
The report comprises:
- On novel drug delivery systems focuses mainly on the oral and injectable formulations of pharmaceuticals and specialty companies.
- It enumerates the various formulation technologies involved in making value added formulations, pharmaceutical applications and advantages of specific technologies.
- The proprietary formulation technologies includes:
- Glide SDI
- Lock Tab
Who should buy this report?
This report will be helpful for those pharmaceutical companies who are exploring novel opportunities for their growth by in-licensing formulation technology or value added pipeline drugs available/being studied in the market.
Request for sample pages: http://www.bharatbook.com/RequestSample.asp?pid=403247
For more information on the report: http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/innovative-drug-delivery-systems-novel-product-and-formulation-technology-licensing-opportunities-for-generic-pharmaceutical-companies.html
About Bharat Book Bureau
Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.
Bharat Book Bureau
UK: +44 7405 208461
USA/Canada - 1-866-279-8368 (Toll free)
India: +91-22-27810772, 27810773
SOURCE Bharat Book Bureau